PortalPublikationenBest way to revascularize patients with main stem and three-...

Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!

Standard

Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated! / Reichenspurner, H; Conradi, L; Cremer, J; Mohr, F W.

in: CLIN RES CARDIOL, Jahrgang 99, Nr. 9, 09.2010, S. 541-544.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Reichenspurner, H, Conradi, L, Cremer, J & Mohr, FW 2010, 'Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!', CLIN RES CARDIOL, Jg. 99, Nr. 9, S. 541-544. https://doi.org/10.1007/s00392-010-0190-2

APA

Reichenspurner, H., Conradi, L., Cremer, J., & Mohr, F. W. (2010). Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated! CLIN RES CARDIOL, 99(9), 541-544. https://doi.org/10.1007/s00392-010-0190-2

Vancouver

Reichenspurner H, Conradi L, Cremer J, Mohr FW. Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated! CLIN RES CARDIOL. 2010 Sep;99(9):541-544. https://doi.org/10.1007/s00392-010-0190-2

Bibtex

@article{0f86a51f28ef41f3995b03db9937e6b3,
title = "Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!",
abstract = "Despite established guidelines for the treatment of coronary artery disease (CAD) by either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), everyday clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by PCI today. However, an abundancy of clinical trials, both observational and randomized has proven the superiority of coronary surgery over PCI in almost every type of multivessel or left main CAD in symptomatic patients. This holds true also for 'hard' endpoints like cardiac death or myocardial infarction as recently demonstrated by the landmark SYNTAX trial. These results have lead to the wording of appropriateness criteria, which integrate current guidelines, evidence from clinical trials and interdisciplinary expert opinion and which express essentially the same message as the SYNTAX trial: {"}CABG remains the standard of care for patients with three-vessel or left main coronary artery disease{"}",
keywords = "Angioplasty, Balloon, Coronary, Coronary Artery Bypass, Coronary Artery Disease/surgery, Humans, Randomized Controlled Trials as Topic, Severity of Illness Index, Treatment Outcome",
author = "H Reichenspurner and L Conradi and J Cremer and Mohr, {F W}",
year = "2010",
month = sep,
doi = "10.1007/s00392-010-0190-2",
language = "English",
volume = "99",
pages = "541--544",
journal = "CLIN RES CARDIOL",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",
number = "9",

}

RIS

TY - JOUR

T1 - Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!

AU - Reichenspurner, H

AU - Conradi, L

AU - Cremer, J

AU - Mohr, F W

PY - 2010/9

Y1 - 2010/9

N2 - Despite established guidelines for the treatment of coronary artery disease (CAD) by either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), everyday clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by PCI today. However, an abundancy of clinical trials, both observational and randomized has proven the superiority of coronary surgery over PCI in almost every type of multivessel or left main CAD in symptomatic patients. This holds true also for 'hard' endpoints like cardiac death or myocardial infarction as recently demonstrated by the landmark SYNTAX trial. These results have lead to the wording of appropriateness criteria, which integrate current guidelines, evidence from clinical trials and interdisciplinary expert opinion and which express essentially the same message as the SYNTAX trial: "CABG remains the standard of care for patients with three-vessel or left main coronary artery disease"

AB - Despite established guidelines for the treatment of coronary artery disease (CAD) by either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), everyday clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by PCI today. However, an abundancy of clinical trials, both observational and randomized has proven the superiority of coronary surgery over PCI in almost every type of multivessel or left main CAD in symptomatic patients. This holds true also for 'hard' endpoints like cardiac death or myocardial infarction as recently demonstrated by the landmark SYNTAX trial. These results have lead to the wording of appropriateness criteria, which integrate current guidelines, evidence from clinical trials and interdisciplinary expert opinion and which express essentially the same message as the SYNTAX trial: "CABG remains the standard of care for patients with three-vessel or left main coronary artery disease"

KW - Angioplasty, Balloon, Coronary

KW - Coronary Artery Bypass

KW - Coronary Artery Disease/surgery

KW - Humans

KW - Randomized Controlled Trials as Topic

KW - Severity of Illness Index

KW - Treatment Outcome

U2 - 10.1007/s00392-010-0190-2

DO - 10.1007/s00392-010-0190-2

M3 - SCORING: Journal article

C2 - 20617323

VL - 99

SP - 541

EP - 544

JO - CLIN RES CARDIOL

JF - CLIN RES CARDIOL

SN - 1861-0684

IS - 9

ER -